Authors:
VANDERHEYDEN S
GHEUENS E
DEBRUIJN E
VANOOSTEROM A
MAES R
Citation: S. Vanderheyden et al., P-GLYCOPROTEIN - CLINICAL-SIGNIFICANCE AND METHODS OF ANALYSIS, Critical reviews in clinical laboratory sciences, 32(3), 1995, pp. 221-264
Authors:
VANDERHEYDEN S
VANSLOOTEN H
DEBRUIJN E
VANOOSTEROM A
Citation: S. Vanderheyden et al., CONTINUOUS LOW-DOSE, ORAL DOXIFLURIDINE (DFURD, 5'-DEOXY-5-FLUOROURIDINE) FOR THE GENERATION OF NONTOXIC 5FU LEVELS IN COLORECTAL-CANCER, European journal of cancer, 31A, 1995, pp. 763-763
Authors:
DEGREEF C
VANDERHEYDEN S
VIANA F
EGGERMONT J
DEBRUIJN EA
RAEYMAEKERS L
DROOGMANS G
NILIUS B
Citation: C. Degreef et al., LACK OF CORRELATION BETWEEN MDR-1 EXPRESSION AND VOLUME-ACTIVATION OFCHLORIDE-CURRENTS IN RAT COLON-CANCER CELLS, Pflugers Archiv, 430(2), 1995, pp. 296-298
Authors:
LAGARDE P
GHEUENS EEO
DEPOOTER CMJ
DEBRUIJN EA
VANDERHEYDEN S
CHOMY F
VANOOSTEROM AT
SCALLIET PG
Citation: P. Lagarde et al., IN-VITRO EFFECTS OF PIRACETAM ON THE RADI OSENSITIVITY OF HYPOXIC CELLS (ADAPTATION OF MTT ASSAY TO HYPOXIC CONDITIONS), Bulletin du cancer, 82(11), 1995, pp. 929-938
Authors:
DIRIX LY
GHEUENS EEO
VANDERHEYDEN S
VANOOSTEROM AT
DEBRUIJN EA
Citation: Ly. Dirix et al., CYTOTOXIC ACTIVITY OF A-L-GLUTAMYLAMINO)-ETHYL)DITHIO)ETHYL)-MITOMYCIN-C AND METABOLITES IN CELL-LINES WITH DIFFERENT RESISTANCE PATTERNS, Anti-cancer drugs, 5(3), 1994, pp. 343-354
Authors:
VANDERHEYDEN S
GHEUENS E
VANDEVRIE W
VANBOCKSTAELE D
VANOOSTEROM A
EGGERMONT A
DEBRUIJN EA
Citation: S. Vanderheyden et al., 5'-DEOXY-5-FLUOROURIDINE INCREASES DAUNORUBICIN UPTAKE IN MULTIDRUG-RESISTANT CELLS AND ITS ACTIVITY IS RELATED WITH P-GP-170 EXPRESSION, Japanese journal of cancer research, 85(1), 1994, pp. 13-16
Authors:
GHEUENS E
VANDERHEYDEN S
ELST H
EGGERMONT A
VANOOSTEROM A
DEBRUIJN E
Citation: E. Gheuens et al., MULTIDRUG-RESISTANCE IN RAT COLON-CARCINOMA CELL-LINES CC531, CC531(MDR+) AND CC531(REV), Japanese journal of cancer research, 84(11), 1993, pp. 1201-1208